Neurocrine Biosciences, Inc. (NBIX) To Present At The 26th Annual Roth Conference
3/5/2014 6:50:04 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) To Present At The Cowen and Company 34th Annual Health Care Conference
2/28/2014 6:35:38 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Prices Public Offering Of Common Stock
2/27/2014 9:50:28 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces NBI-98854 Scientific Presentations At The International Parkinson And Movement Disorder Society's 18th Annual Congress
2/25/2014 6:27:46 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) To Present At The Leerink Swann and Company Global Healthcare Conference
2/7/2014 8:38:29 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Reports Fourth Quarter And Year End 2013 Results
2/7/2014 6:10:01 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call And Webcast To Report Fourth Quarter And Year-End 2013 Financial Results
2/4/2014 7:25:56 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Rockets On Positive Phase 2 Movement Disorder Drug Data; Stock Up +75.56% At Market Close (January 7, 2014)
1/7/2014 7:22:42 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) To Present At Oppenheimer's 24th Annual Healthcare Conference
12/5/2013 6:09:55 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) To Present At Deutsche Bank (DB) 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference
11/27/2013 6:41:06 AM
More...
|
|